ORKA
Oruka Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ORKA Filings
Filing Date
Form Description
Form Type
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-12
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-12 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-05
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-05 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-05
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-05 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-10-17
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-17 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-14
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
2025-10-14 ·
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
2025-10-14
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
2025-10-14 ·
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
2025-10-03
Form S-3 - Registration statement under Securities Act of 1933
2025-10-03 ·
Form S-3 - Registration statement under Securities Act of 1933
2025-10-03
Form S-3 - Registration statement under Securities Act of 1933
2025-10-03 ·
Form S-3 - Registration statement under Securities Act of 1933
2025-09-24
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-09-24 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
